title: Platinoid complexes to target monomeric disordered peptides: a forthcoming solution against amyloid diseases?
abstract: In the present Frontier article, we highlight recent new results on the use of platinoid complexes as therapeutic agents against Alzheimer's disease and infer the relevance of targeting monomeric soluble disordered amyloid peptides to preclude the deleterious aggregation process associated with the etiology of the disease.
authors: CNRS, LCC (Laboratoire de Chimie de Coordination), 205, route de Narbonne, F-31077 Toulouse, France. christelle.hureau@lcc.toulouse.fr.
authors: Christelle
authors: C
authors: Hureau
authors: Peter
authors: P
authors: Faller
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D056831:Coordination Complexes / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D010984:Platinum / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D016229:Amyloid beta-Peptides; D056831:Coordination Complexes; D010984:Platinum